APA (7th ed.) Citation

EB, E., E, A., T, G., W, L., PF, B., SM, M., . . . EM, I. (2022). Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: Long-term follow-up of three phase I clinical trials. Journal for immunotherapy of cancer, 10(5), . https://doi.org/10.1136/jitc-2021-004345

Chicago Style (17th ed.) Citation

EB, Ellingsen, et al. "Durable and Dynamic HTERT Immune Responses Following Vaccination with the Long-peptide Cancer Vaccine UV1: Long-term Follow-up of Three Phase I Clinical Trials." Journal for Immunotherapy of Cancer 10, no. 5 (2022). https://doi.org/10.1136/jitc-2021-004345.

MLA (9th ed.) Citation

EB, Ellingsen, et al. "Durable and Dynamic HTERT Immune Responses Following Vaccination with the Long-peptide Cancer Vaccine UV1: Long-term Follow-up of Three Phase I Clinical Trials." Journal for Immunotherapy of Cancer, vol. 10, no. 5, 2022, https://doi.org/10.1136/jitc-2021-004345.